Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-124367 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 25, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
334,231
Total Value
$12,282,814.39
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Mar 23, 2026 | Exercise/Conversion | 84,400 | $29.64 | $2,501,616.00 | 152,452 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 23, 2026 | Sale | 22,756 | $76.73 | $1,746,133.87 | 129,696 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 23, 2026 | Sale | 52,975 | $77.21 | $4,089,982.55 | 76,721 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 23, 2026 | Sale | 8,214 | $78.40 | $643,950.49 | 68,507 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 23, 2026 | Sale | 6,105 | $79.87 | $487,608.79 | 62,402 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 23, 2026 | Sale | 1,200 | $80.05 | $96,060.00 | 61,202 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 25, 2026 | Exercise/Conversion | 24,727 | $29.64 | $732,908.28 | 85,929 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 25, 2026 | Sale | 24,727 | $80.26 | $1,984,554.40 | 61,202 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Mar 23, 2026 | Exercise/Conversion | 84,400 | $0.00 | $0.00 | 115,600 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Mar 25, 2026 | Exercise/Conversion | 24,727 | $0.00 | $0.00 | 90,873 | Direct | โ | View Details |